Antiviral Treatments Reduce Cancer Risk for HIV Patients
MONDAY, June 11, 2018 -- Long-term antiviral treatment cuts the risk of cancer in HIV patients as they age, a new study says.
People with HIV are at increased risk for both AIDS-related cancers (Kaposi sarcoma, non-Hodgkin lymphoma or invasive... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 11, 2018 Category: General Medicine Source Type: news
Power morcellation: Questions linger for controversial tech
Dr. Amy Reed’s tragic case brought to light the cancer risks posed by power morcellation. Her death hasn’t stopped lingering questions about the technology.
Power morcellators were used for 20 years to laparoscopically remove fibroids, benign tumors of the uterus, raising not a single adverse event report with the FDA. That all changed in 2013, when Dr. Amy Reed, an attending physician at Beth Israel Deaconess Medical Center, underwent a myomectomy using power morcellation at nearby Brigham & Women’s Hospital.
Reed’s fibroids were not benign, but instead a malignant form of cancer called uterine sarcoma...
Source: Mass Device - June 1, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Gynecological Legal News News Well Recalls Regulatory/Compliance Surgical Cancer eximissurgical johnsonandjohnson powermorcellators Source Type: news
The Global Incidence of Kaposi's Sarcoma in the HIV/AIDS Era The Global Incidence of Kaposi's Sarcoma in the HIV/AIDS Era
A new review provides insight into the global incidence of Kaposi ' s sarcoma among HIV-infected individuals.HIV Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 23, 2018 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news
CytRx Corporation Names Eric L. Curtis as Its President and Chief Operating Officer
Seasoned Professional with 25 Years of Experience in Both Oncology and Orphan Diseases, Including Development and Commercialization of Approved Drugs Votrient, Doxil, Velcade and Benlysta
LOS ANGELES, May 3, 2018 -- (Healthcare Sales & Marketing Network... Biopharmaceuticals, Oncology, Personnel CytRx, aldoxorubicin, soft tissue sarcoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 3, 2018 Category: Pharmaceuticals Source Type: news
Molecular culprit behind virus-mediated chronic inflammation and cancers identified
(PLOS) Within cells infected by Kaposi sarcoma herpesvirus (KSHV), the human protein CADM1 interacts with viral proteins to promote chronic inflammation, which plays a major role in the development of cancers caused by KSHV. Richard Hunte of the University of Miami, Fla., and colleagues present these new findings in PLOS Pathogens. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 26, 2018 Category: Infectious Diseases Source Type: news
New connections: Ewings sarcomas driver is its Achilles heel
Several studies identify drug combinations that target or exploit the EWS-FLI1 fusion protein to kill Ewing’s sarcoma cells. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - April 24, 2018 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news
Crizotinib: New Standard for ALK+ Myofibroblastic Tumor Crizotinib: New Standard for ALK+ Myofibroblastic Tumor
With 100% disease control rates in patients with ALK+ inflammatory myofibroblastic tumor -- a very rare type of soft tissue sarcoma -- crizotinib should be the standard of care, say experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 16, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
A potential new therapeutic target for Ewing sarcoma
(IDIBELL-Bellvitge Biomedical Research Institute) IDIBELL researchers correlate EphA2 membrane receptor with the metastatic capacity of tumors in Ewing sarcoma.Ewing sarcoma is the second most frequent bone cancer among children and adolescents, and it is characterized by its aggressiveness and tendency to metastasize.Researchers are currently working on nanoengineering a molecule capable of blocking EphA2 and deliver drugs in a targeted manner.Research was possible thanks to the backing of Alba P é rez Foundation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 5, 2018 Category: Cancer & Oncology Source Type: news
NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas
Progression-free survival is the length of time patients lived before their disease worsened. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - March 28, 2018 Category: American Health Source Type: news
Zimbabwe:33% of Cancers Aids Related
[263Chat] Aids related cancers namely Kaposi Sarcoma, Cervical Cancer, Non-Hodgkins Lymphoma and Squamous Cell Carcinoma of the conjunctiva continue to occupy high positions in cancer rankings, according to Zimbabwe National Cancer Registry report. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 22, 2018 Category: African Health Source Type: news
Greehey Institute team finds link between BRCA1 and Ewing sarcoma
(University of Texas Health Science Center at San Antonio) Scientists with the Greehey Children's Cancer Research Institute at UT Health San Antonio have discovered a surprising connection between a breast cancer protein, BRCA1, and a pediatric cancer called Ewing sarcoma. Their findings were made public March 7 online in the journal Nature. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 7, 2018 Category: Cancer & Oncology Source Type: news
Scientists tackle the aberrant epigenetic programming underlying childhood cancers
(Write Science Right) Researchers at UFRGS and the US NIH have targeted proteins that regulate chromatin in Ewing sarcoma cells, hindering malignant tumor growth. They induced chromatic relaxation by treating the cells with histone deacetylase inhibitors, reducing expression of the EWSR1-FLI-1 oncogene and other pluripotency/cell viability genes, while impairing sarcoma cell survival and growth. Decreased survival of stem-like cancer cells and re-expression of a neuronal differentiation marker were also observed. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2018 Category: International Medicine & Public Health Source Type: news
FDA Again Advises Against Morcellators for Fibroids FDA Again Advises Against Morcellators for Fibroids
The risk for uterine sarcoma being found in fibroids is too high, notes Dr Markman.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 8, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
Unique research approach finds FDA-approved drug shuts down Ewing sarcoma cells in lab
(Georgetown University Medical Center) Based on a novel approach to drug discovery, researchers at Georgetown Lombardi Comprehensive Cancer Center say an agent approved to treat a type of leukemia might also help young people with a much rarer and aggressive form of cancer, Ewing sarcoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 30, 2018 Category: Cancer & Oncology Source Type: news
Adult Soft Tissue Sarcoma
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 29, 2018 Category: General Medicine Source Type: news
